Abstract.
Background:
Cognitive impairment may occur at any time during the course of multiple sclerosis (MS), and it is often a major cause of disability in patients with the disease. The APOE-ε4 allele is the major known genetic risk factor for late onset familial and sporadic Alzheimer’s Disease (AD), and it seems to be implicated in cognitive decline in normal elderly persons.
Objective:
To investigate the clinical and genetic variables that can be associated with the cognitive decline in patients with MS.
Methods:
Five-hundred and three patients with clinically definite MS underwent a battery of neuropsychological tests and, according to the number of failed tests, were divided into cognitively normal and impaired. All patients were genotyped for APOE gene polymorphisms.
Results:
Fifty-six percent of MS patients showed, to different extents, cognitive impairment. Cognitive decline was predominant in men and was associated with disease duration, Kurtzke Expanded Disability Status Scale (EDSS) score, a low level of education, and, interestingly, the ε4 allele of the APOE gene. By contrast, cognitive impairment in women was independent of any investigated variable.
Conclusion:
The findings demonstrate that clinical and genetic factors play a role in men affected by MS developing cognitive impairment.
Similar content being viewed by others
References
Amato MP, Ponziani G, Siracusa G, Sorbi S (2001) Cognitive dysfunction in early-onset multiple sclerosis. A reappraisal after 10 years. Arch Neurol 58:1602–1606
Beatty WW (1993) Memory and “frontal lobe” dysfunction in multiple sclerosis. J Neurol Sci 115:S38–S41
Beatty WW, Aupperle RL (2000) Sex differences in cognitive impairment in multiple sclerosis. Clin Neuropsychol 16:472–480
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Bobholz JA, Rao SM (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16:283–288
Borkowsky JG, Benton AL, Spean D (1967) Word fluency and brain damage. Neuropsychologia 5:135–140
Brassington JC, Marsh NV (1998) Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 8:43–77
Caltagirone C, Gainotti G, Masullo C, Miceli G (1979) Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiat Scand 60:50–56
Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 36:378–384
Comi G, Filippi M, Martinelli V, Sirabian G, Visciani A, Compi A, Manni S, Rovaris M, Canal N (1993) Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. J Neurol Sci 115 (Suppl):S66–S73
Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ (2001) Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Neurology 57:2217–22
Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schiefermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Grass R, Wimmer G, Vass K, Pfeiffer KH,Hartung HP, Schmidt R (2001) Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57:853–857
Ferri C, Sciacca FL, Veglia F, Martinelli F, Comi G, Canal N, Grimaldi LM (1999) APOE epsilon2 -4 and -491 polymorphisms are not associated with MS. Neurology 53:888–889
Gainotti G, Miceli G, Caltagirone C (1977) Constructional apraxia in leftbrain-damaged patients: a planning disorder? Cortex 13:109–118
Gandy S (2003) Estrogen and Neurodegeneration. Neurochem Res 28:1003–1008
Garcia-Segura LM, Azcoitia I, DonCarlos LL (2001) Neuroprotection by estradiol. Prog Neurobiol 63:29–60
Guo SW, Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361–372
Hohol MJ, Guttmann CR, Orav J, Mackin GA, Kikinis R, Khoury SJ, Jolesz FA, Weiner HL (1997) Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 54:1018–1025
Ignatius MJ, Gebicke-Harter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, Schooter EM (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 83:1125–1129
Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622–630
Miller DH, Grossmann RI, Reingold SC, McFarland HF (1998) The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121:3–24
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple Sclerosis. N Engl J Med 343:938–952
Oliveri RL, Cittadella R, Sibilia G, Manna I, Valentino P, Gambardella A, Aguglia U, Zappia M, Romeo N, Andreoli V, Bono F, Caracciolo M, Quattrone A (1999) APOE and risk of cognitive impairment in multiple sclerosis. Acta Neurol Scand 100:290–295
Poser CM, Paty DW, Scheinberg L, Mc-Donald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231
Rao SM (1986) Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol 8:503–542
Rao SM (1997) Neuropsychological aspects of multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW (eds) Multiple Sclerosis: Clinical and Pathological Basis. Chapman & Hall London, England, pp 357–362
Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L (1989) Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 39:161–166
Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis: frequency, patterns and prediction. Neurology 41:685–691
Raven JC (1947) Progressive Matrices Sets A, Ab, B: Board and Book forms. HK Lewis, London
Rey A (1964) Mémorisation d’une série de 15 mots en 5 repetitions. In: Rey A ed) L’examen clinique en psychologie. Presses Universitaire de France, Paris
Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McCown N (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43:1467–1472
Schneider S, Roessli D, Excoffier L (2000) Arlequin, version 2000: a software for population genetics data analysis.Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva, Geneva
Weinshenker BG, Rice GPA, Noseworthy JH, Carriere W, Baskerville J, Ebers GC (1991) The natural history of multiple sclerosis: a geographically based study 3. Multivariate analysis of predictive factors and models of outcome. Brain 114:1045–1056
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported in part by a grant from FISM (Federazione Italiana Sclerosi Multipla).
Rights and permissions
About this article
Cite this article
Savettieri, G., Messina, D., Andreoli, V. et al. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 251, 1208–1214 (2004). https://doi.org/10.1007/s00415-004-0508-y
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00415-004-0508-y